Alzheimer's Disease: Presenilin 2-Sparing γ-Secretase Inhibition Is a Tolerable Aβ Peptide-Lowering Strategy

Tomas Borgegård(AstraZeneca (Sweden)), Johan Lundkvist(Karolinska Institutet)

Journal of Neuroscience

November 28, 2012

10.1523/jneurosci.1451-12.2012

Cited by 44

Related Papers

No related papers found

Powered by citation graph analysis